Sophos named a Leader in the Gartner® Magic Quadrant™ for EPP

A Leader, for the 14th Time

2023 Gartner® Magic Quadrant™ for Endpoint Protection Platforms

Threats change. Sophos continues to be recognized.

For the 14th consecutive time, Sophos has been named as a Leader in the 2023 Gartner® Magic Quadrant™ for Endpoint Protection Platforms.

We believe this ongoing recognition is a testament to our relentless innovation, deep threat expertise, and continuing adaptation that enables us to defend customers from even the most sophisticated adversaries.

Read the Report

Choose Endpoint Protection that works for you and with you

Sophos Endpoint delivers unparalleled threat protection and powerful EDR and XDR tools. Designed for real-world environments and real-world threats, highlights include:

•

CryptoGuard anti-ransomware protection that detects and rolls-back both local and remote ransomware attacks

•

60+ exploit mitigations that are deployed automatically – no configuration required

•

Adaptive Attack Protection which automatically applies more aggressive protection when a device is under attack

•

Critical Attack Warning that identifies an active estate-wide attack and proactively notifies customers so they can take immediate preventative action

Explore Sophos Endpoint

Gartner, Magic Quadrant for Endpoint Protection Platforms, Peter Firstbrook, Chris Silva, 31 December 2023

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, Magic Quadrant is a registered trademarks of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.